16 November 2020: Clinical Research
A Mobile App for Diabetes Management: Impact on Self-Efficacy Among Patients with Type 2 Diabetes at a Community Hospital
Yangkui Zhai 1ABEG* , Wenjuan Yu 2EFDOI: 10.12659/MSM.926719
Med Sci Monit 2020; 26:e926719
Table 1 Demographic and baseline characteristics.
| Characteristics | App group (n=60) | Control group (n=58) | P-value |
|---|---|---|---|
| Age (years), mean±SD | 54.12±11.1 | 55.64±14.2 | 0.710 |
| Male, n (%) | 30 (52.6%) | 28 (51.8%) | 0.672 |
| High school and above, n (%) | 12 (21.1%) | 10 (18.5%) | 0.811 |
| Duration of T2DM(years), mean±SD | 11.7±5.49 | 12.1±3.25 | 0.087 |
| BMI (kg/m) | 26.41±3.41 | 25.57±3.33 | 0.191 |
| HbA1c (%), mean±SD | 8.86±1.15 | 9.05±1.23 | 0.795 |
| Fasting plasma glucose (mmol/L, mean±SD | 8.16±2.57 | 8.54±2.91 | 0.821 |
| Postprandial plasma glucose (mmol/L), mean±SD | 14.26±3.11 | 14.70±2.64 | 0.741 |
| Triglyceride (mmol/L), mean±SD | 2.11±1.47 | 1.99±1.45 | 0.375 |
| LDL (mmol/L), mean±SD | 3.25±1.06 | 3.41±0.74 | 0.812 |
| Urine ACR (mg/mmol), mean±SD | 2.85±1.21 | 3.04±1.18 | 0.446 |
| T2DM – type 2 diabetes mellitus; BMI – body mass index; Hb – glycated hemoglobin; LDL – low-density lipoprotein; ACR – albumin/creatine ratio. | |||